Shapiro E T, Polonsky K S, Copinschi G, Bosson D, Tillil H, Blackman J, Lewis G, Van Cauter E
Department of Medicine, University of Chicago, Illinois 60637.
J Clin Endocrinol Metab. 1991 Feb;72(2):444-54. doi: 10.1210/jcem-72-2-444.
To define the spontaneous diurnal variations in glucose regulation during fasting in noninsulin-dependent diabetes (NIDDM), we measured circulating levels of glucose, insulin, C-peptide, GH, cortisol, and glucagon at 15-min intervals in 11 patients with untreated diabetes and 7 matched control subjects studied during a 24-h period. The rates of insulin secretion were derived from the concentrations of C-peptide by deconvolution using a two-compartment mathematical model for C-peptide distribution and metabolism. In both groups of subjects, despite continued fasting, glucose levels stopped declining in the evening and subsequently rose throughout the night to reach a morning maximum. Elevated levels persisted until noon. The morning glucose maximum corresponded to a relative increase of 23.8 +/- 5.5% above the evening nadir in NIDDM patients and 13.2 +/- 4.6% in nondiabetic subjects (P less than 0.05). In NIDDM patients, insulin levels and insulin secretion rates did not parallel the nocturnal glucose changes. In contrast, in control subjects, this nocturnal glucose rise coincided with a similar increase in insulin secretion rates. Cortisol concentrations in patients with NIDDM were higher than those in control subjects throughout the study period (P less than 0.001) and rose earlier in the evening than in control subjects, thus failing to demonstrate the normal nocturnal suppression. In both groups of subjects, the nighttime glucose elevation was temporally and quantitatively correlated with the circadian cortisol rise. GH secretion was increased in the evening and nighttime periods compared to the daytime values, and in NIDDM patients, but not in control subjects, the size of the morning glucose elevation was directly related to the magnitude of this increase in GH secretion (r = 0.88; P less than 0.01). Glucagon concentrations were similar in both groups of subjects and remained essentially constant throughout the study period. We hypothesize that the nocturnal glucose rise that occurs during fasting represents a normal diurnal variation in the set-point of glucose regulation amplified by counterregulatory mechanisms activated by the fasting condition.
为了确定非胰岛素依赖型糖尿病(NIDDM)患者禁食期间血糖调节的自发性昼夜变化,我们在24小时内,每隔15分钟测量11例未经治疗的糖尿病患者和7例匹配的对照受试者的血糖、胰岛素、C肽、生长激素(GH)、皮质醇和胰高血糖素的循环水平。胰岛素分泌率通过使用两室数学模型对C肽分布和代谢进行反卷积,从C肽浓度推导得出。在两组受试者中,尽管持续禁食,但血糖水平在傍晚停止下降,随后在整个夜间上升,直至早晨达到最高值。较高水平一直持续到中午。早晨血糖最高值在NIDDM患者中比傍晚最低点相对升高23.8±5.5%,在非糖尿病受试者中为13.2±4.6%(P<0.05)。在NIDDM患者中,胰岛素水平和胰岛素分泌率与夜间血糖变化不平行。相反,在对照受试者中,这种夜间血糖升高与胰岛素分泌率的类似增加同时出现。在整个研究期间,NIDDM患者的皮质醇浓度高于对照受试者(P<0.001),且在傍晚比对照受试者更早升高,因此未表现出正常的夜间抑制。在两组受试者中,夜间血糖升高在时间和数量上与昼夜皮质醇升高相关。与白天相比,GH分泌在傍晚和夜间增加,在NIDDM患者中,早晨血糖升高的幅度与GH分泌增加的幅度直接相关(r = 0.88;P<0.01),但在对照受试者中并非如此。两组受试者的胰高血糖素浓度相似,且在整个研究期间基本保持恒定。我们推测,禁食期间出现的夜间血糖升高代表了血糖调节设定点的正常昼夜变化,这种变化被禁食状态激活的反调节机制放大。